GEM

Indian Army Formoterol Budesonide Rotacap, Frusemide, Haloperidol & Hydrochlorothiazide Tender Central Delhi 2025

Posted

27 Oct 2025, 01:14 pm

Deadline

15 Nov 2025, 01:00 pm

Progress

Issue27 Oct 2025, 01:14 pm
AwardPending
Explore all 4 tabs to view complete tender details

Quantity

129300

Category

FORMOTEROL (6MCG) + BUDESONIDE (400MCG) ROTACAP

Bid Type

Two Packet Bid

Key Highlights

  • CRITICAL: Indian Army procurement of multi-item pharmaceutical formulations from CENTRAL DELHI
  • Specific product names: Formoterol + Budesonide Rotacap, Frusemide 40 MG tab, Haloperidol 5 MG tab, Hydrochlorothiazide 12.5 MG tab
  • No BOQ, quantities, or estimated value disclosed; expect clarifications or addenda
  • ATC document exists; bidders must review buyer terms not fully shown in data
  • Potential regulatory and supply-chain requirements typical to government pharma tenders
  • No explicit warranty, penalties, or payment terms provided in initial data

Categories 1

Tender Overview

The procurement is for the Indian Army, Department Of Military Affairs, located in CENTRAL DELHI, DELHI. The listed product categories include Formoterol (6MCG) + Budesonide (400MCG) Rotacap, Frusemide 40 MG tablets, Haloperidol 5 MG tablets, and Hydrochlorothiazide 12.5 MG tablets. The tender lacks BOQ items and explicit quantities or estimated value. This opportunity targets suppliers capable of supplying multiple pharmaceutical formulations under centralized military procurement. Key differentiators include cross-category medicine supply with potential regulatory compliance expectations and army-specific distribution terms. No start/end dates are provided in the data.

Technical Specifications & Requirements

  • Product names and categories explicitly listed: Formoterol + Budesonide Rotacap, Frusemide tablets, Haloperidol tablets, Hydrochlorothiazide tablets.
  • No technical standards or packaging specifications were provided in the tender data.
  • No BOQ quantities or estimated contract value disclosed.
  • Tender appears to be a multi-product pharmaceutical supply for military use, requiring reliable cold-chain/stock management may be implied by product types, though not stated.
  • Supplier must be prepared to align with Indian Army procurement processes and any undisclosed compliance requirements.
  • Since no specs are documented, bidders should seek clarifications on dosage form, packaging, expiry, and regulatory approvals prior to submission.

Terms, Conditions & Eligibility

  • No EMD amount or percentage is stated in the tender data.
  • No delivery timeline or payment terms are specified.
  • No explicit eligibility criteria (experience, turnover, or certifications) are disclosed.
  • Buyer uploaded ATC document is referenced, suggesting there are additional, unseen terms.
  • Bidders should request the ATC file and inquire about GST, PAN, and OEM authorizations, given standard government pharmacy procurement practices.
  • Participation would likely require compliance with relevant Indian regulatory standards and Army-specific submission requirements not detailed here.

Key Specifications

  • Product names and categories: Formoterol + Budesonide Rotacap, Frusemide tablets, Haloperidol tablets, Hydrochlorothiazide tablets

  • Quantities/values: Not specified in data; await BOQ or addenda

  • EMD/estimated value: Not disclosed; verify via ATC and tender notice

  • Experience: Not stated; likely government pharma supply experience required

  • Quality/compliance: Regulatory approvals implied; confirm ISI/ISO if applicable for packaging

Terms & Conditions

  • EMD amount and payment terms not disclosed; verify in ATC

  • Delivery schedule not provided; confirm lead times in addendum

  • Penalties and performance bonds not specified; check standard government procurement clauses

Important Clauses

Payment Terms

Not disclosed; bidders must review ATC for advance/LC terms and schedule

Delivery Schedule

Not disclosed; clarify expected delivery windows and penalties in ATC

Penalties/Liquidated Damages

Not specified; unknown LD rates; refer to ATC for final figures

Bidder Eligibility

  • Experience supplying pharmaceutical products to government or defense sectors

  • GST registered with valid PAN, and compliance with drug regulations

  • Ability to meet army procurement processes and documentation requirements

AI-Powered Bidder Prediction

Companies most likely to bid

Unlock Bidder Insights

AI predictions on likely bidders

Required Documents

1

GST registration certificate

2

Permanent Account Number (PAN) card

3

Experience certificates for pharmaceutical supply to government or large institutions

4

Financial statements proving stability (last 2-3 years)

5

EMD submission documents (as per ATC/notice, if required)

6

Technical bid documents and product compliance certificates

7

OEM authorizations or distributorship letters for listed medicines

Frequently Asked Questions

What documents are required for this pharmaceutical tender in Central Delhi

Bidders must submit GST registration, PAN, experience certificates for government pharma supply, financial statements, EMD documents if specified, technical bid, and OEM authorizations. Review the ATC document for any additional forms or declarations required by the Indian Army procurement.

How to participate in Indian Army medicine procurement tender in Delhi 2025

Register as a supplier with the Indian Army portal, obtain required certifications, and submit a technical bid aligned with listed medicines: Formoterol + Budesonide Rotacap, Frusemide, Haloperidol, and Hydrochlorothiazide. Await ATC clarifications on BOQ, delivery timelines, and payment terms before submission.

What are the technical specifications for Formoterol Rotacap in this tender

No explicit specifications are provided in the data. Candidates should obtain the ATC and confirm Formoterol (6MCG)/Budesonide (400MCG) Rotacap dosage form, packaging, expiry, batch size, and regulatory approvals required by the Army before bid submission.

What is the EMD amount for the Indian Army medicine procurement in Delhi

The EMD amount is not disclosed in the tender data. Bidders must consult the ATC to determine the exact EMD amount, submission method (online/DD), and validity period.

When is the delivery deadline for the listed medicines in this bid

Delivery timelines are not specified in the available data. Respondents should verify required lead times and any phased delivery schedules in the ATC and ensure capability to meet army distribution requirements.

What documents verify eligibility for Indian Army pharmaceutical tenders in Delhi

Eligibility typically includes GST, PAN, pharma-specific certifications, prior government/defense supply experience, and OEM authorization letters. Confirm with ATC for any mandatory pre-qualification criteria and technical compliance certificates.

How to ensure compliance with army procurement processes for medicines

Engage with the official Indian Army procurement portal, obtain ATC access, align submission with listed medicines, and prepare product compliance documentation, cold-chain capability (if required), and regulatory approvals per Indian pharmaceutical norms.

What standards or certifications are required for listed medicines in this tender

Standards are not specified in the data. Verify with ATC whether ISI, GMP, GLP, or other regulatory certifications apply, and ensure packaging and labeling meet government procurement requirements before submission.